Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?

To: technetx who wrote (59)	5/5/1998 6:43:00 AM
From: Thomas Kirwin	Read Replies (1) \| Respond to of 422

Immucor's Independent Future Dominic, IMHO - The possibility for a buyout at this stage is slim to none as Immucor's CEO/Pres. Mr. Gallup appears to be growing the reagent and medical device segments very well. The recent earnings report was impressive when compared to earlier reports. The board of directors has been greatly strengthened with the addition of top people from other companies. I believe that this strategy will improve sales and market share. Recently announced alliances or marketing initiatives will only add to the bottom line as we await approval of the ABS2000. My confidence in Immucor's prospects is high. The stock price has been holding up well. In fact, the period prior to the recent earnings release did not present an opportunity to buy the stock at depressed levels as has been the case in the past. Looking good! Of course anything can happen and yes Abbott Labs just may make Immucor an offer they cannot refuse. :-) Regards, Tom

To: technetx who wrote (59)	5/12/1998 12:39:00 AM
From: Thomas Kirwin	Respond to of 422

Immucor's Web Site! Technetx, Immucor has a web site that is very rich in content. Take a look! immucor.com Regards, Tom

To: technetx who wrote (59)	5/25/1998 10:59:00 AM
From: Thomas Kirwin	Respond to of 422

Abbott Labs/Johnson & Johnson Technetx, The plot thickens.... Other high level Immucor Management Team Members have ties to Abbott Labs in addition to J&J. Don't forget Schering Plough Corporation, American Hoeschst Corporation, Biological Corporation of America and Clinical Sciences, Inc. immucor.com Ronald A. Andrews, Vice President - Marketing immucor.com Ronnie Andrews is vice president of marketing for Immucor and has been with the company since 1995. Mr. Andrews is responsible for strategic and tactical marketing efforts, as well as implementing instrument development programs. Mr. Andrews brings more than 10 years of industry experience primarily with Abbott Laboratories Diagnostics Division as senior marketing manager of the Business Unit Operations for Clinical Chemistry Products. He is actively involved in the American Association of Blood Banks and the Clinical Laboratory Managers Association. A graduate of Wofford College, Mr. Andrews earned his bachelor's degree in biology and chemistry and completed the EMBA program through Abbott Diagnostics' program at the University of Chicago. Dr. Gioacchino De Chirico, President and Managing Director, Immucor Italia S.r.l. (Italy) immucor.com Dr. De Chirico has been President of Immucor Italia S.r.l. since February 1994. From 1989 until 1994, he was employed in the United States by Ortho Diagnostics Systems, Inc., a Johnson and Johnson Company, as General Manager, Immunocytometry, with worldwide responsibility. From 1979 until 1989, he was with Ortho Diagnostics Systems, Inc., in Italy, where he began as a sale representative and held several management positions, including Product Manager and European Marketing Manager for Immunology and Infectious Disease products. Regards, Tom